Medicare Coverage for COPD: Oxygen, Inhalers, Pulmonary Rehab, and the Part B vs Part D Split

Chronic obstructive pulmonary disease is one of the most common conditions in the Medicare population, and it generates some of Medicare's most counterintuitive coverage situations. The same medication can be covered under Part B or Part D depending on how it is administered. Home oxygen has specific qualification criteria and a complex 36-month payment structure. And pulmonary rehabilitation, one of the most effective interventions for COPD, goes almost unused because most patients do not know Medicare covers it. Understanding how Medicare handles COPD from diagnosis to long-term management means you can use every benefit available without unexpected cost surprises.

Bryce's Take

The drug that goes in your nebulizer is covered under Part B as DME, while the same drug class in inhaler form is covered under Part D. If you are on both, you are dealing with two separate billing pathways simultaneously. Getting the billing right means getting the right coverage applied, and I walk through this with COPD clients regularly because the confusion between the two is genuinely common.

The inhaler versus nebulizer coverage split

This is the distinction that surprises COPD patients and their pharmacies most often. Inhaled medications administered through a metered-dose inhaler or dry powder inhaler are covered under Medicare Part D as prescription drugs. The same medication administered through a nebulizer machine is covered under Medicare Part B as a durable medical equipment supply, the nebulizer is DME, and the drug that goes in it is covered under the Part B DME umbrella. If you use both an inhaler version and a nebulizer version of a similar drug class, you may be dealing with two separate billing channels simultaneously. Understanding which channel applies to each medication prevents coverage denials and unexpected bills.

Home oxygen coverage under Part B

Medicare Part B covers home oxygen equipment when your physician certifies that your blood oxygen level is at or below specific thresholds. The qualification criteria require either an arterial blood gas showing PaO2 at or below 55 mmHg, or an oxygen saturation measurement showing SpO2 at or below 88%. Measurements taken while at rest, during exercise, or during sleep can each support qualification under different circumstances. The physician must document the qualifying measurement and certify medical necessity. Covered equipment includes stationary oxygen concentrators, portable oxygen concentrators, liquid oxygen systems, and associated supplies including tubing, masks, and cannulas.

The 36-month oxygen coverage rule

Medicare's payment for home oxygen follows a specific timeline. For the first 36 months, Medicare pays monthly rental fees to the oxygen supplier. After 36 months of continuous use, Medicare stops paying monthly rental but the equipment remains with you and you own it. However, Medicare continues to cover maintenance and service of the equipment, ongoing supply replacement, and any necessary equipment upgrades. If your oxygen need ends and restarts within a period of time, the 36-month clock may reset depending on the duration of the gap. This structure means long-term oxygen users eventually receive their equipment with Medicare continuing to support its maintenance.

Pulmonary rehabilitation under Part B

Medicare Part B covers pulmonary rehabilitation for patients with moderate to severe COPD, defined as GOLD stage II or higher on the COPD severity scale. Coverage is similar in structure to cardiac rehabilitation: up to 36 sessions in a 36-week period, with the option for additional sessions if medically necessary and physician-certified. Each session includes exercise training, education about COPD management, and psychosocial support, all under medical supervision at a hospital outpatient department or physician-supervised pulmonary rehab program. The evidence for pulmonary rehab is strong, it reduces hospitalizations, improves exercise capacity, and improves quality of life. Standard 20% Part B coinsurance applies; Medigap Plan G or N covers this.

Spirometry and diagnostic testing

Pulmonary function tests including spirometry are covered under Part B when used to diagnose or monitor COPD and other lung conditions. These tests are performed in a physician's office, clinic, or hospital outpatient setting and subject to standard Part B cost-sharing. Peak flow meters, used at home to monitor lung function, may be covered as DME under Part B when medically necessary and prescribed by a physician.

COPD medications under Part D

Inhaled corticosteroids, long-acting beta-agonists, long-acting muscarinic antagonists, and combination inhalers are covered under Medicare Part D. The specific drugs covered and their cost-sharing tier depend on your plan's formulary. Many of the most effective COPD inhalers are brand-name medications on Tier 3 or Tier 4, which can carry significant copays. Reviewing your Part D formulary specifically for your COPD medications during the Annual Enrollment Period, and comparing plans based on actual drug costs, is particularly valuable for patients on multiple respiratory medications.

Bryce Casson

Licensed Independent Medicare Broker

Bryce Casson is an independent Medicare insurance broker who works with every major carrier. He does not represent any single insurer, which means his recommendations are based on what actually fits each client's situation, not on commissions or quotas.